An Indian blood test that reads thousands of small molecules in serum; its developer reports about 98% accuracy for 30 cancers, figures that have not been checked independently.
PredOmix Technologies of Gurugram, India, with a Singapore affiliate, has published a version for four cancers in women (Gupta et al., Scientific Reports 2022), a version for 15 cancers in women reported as identifying all cancer-positive samples with more than 99% accuracy (Gupta et al., Scientific Reports 2023), and, in an investigator-initiated trial with HCG cancer centres of 6,445 people (CTRI/2023/03/050316; Nagarkar et al., Cancer Reports 2024), a version for 30 cancers in women and men with an average accuracy of about 98% that did not vary by stage. A study of OncoVeryx-F for ovarian cancer (Nagarkar et al., International Journal of Women's Health 2024) reported stage I detection accuracy above 98%. None of the abstracts gives sensitivity at a stated specificity, cancers counted by type and stage, or a screening-population result. Company employees wrote the papers. No CDSCO or other regulatory status, availability or price was found.
Untargeted mass spectrometry of serum metabolites, classified by machine learning first as cancer or no cancer and then by tissue of origin.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"OncoVeryx" OR ABSTRACT:"OncoVeryx" OR TITLE:"PredOmix" OR ABSTRACT:"PredOmix" OR TITLE:"OncoVeryx-F" OR ABSTRACT:"OncoVeryx-F" OR TITLE:"PredOmix metabolome test" OR ABSTRACT:"PredOmix metabolome test") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about OncoVeryx (PredOmix), not a curated reading list.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA) and the tags test, mced.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/